Povidone Iodine and Cesarean Section Wound Infections
Povidone Iodine 10% Versus 7.5% Hand Scrub and Cesarean Section Wound Infections: A Randomized Trial
1 other identifier
interventional
3,231
1 country
1
Brief Summary
The aim of this randomized clinical trial is to compare the efficiency of hand scrubbing by Povidone-Iodine solution 10% over 7.5% concentration in decreasing post-cesarean section wound infections \& compare side effects of both agents.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_3
Started Jan 2012
Shorter than P25 for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2012
CompletedFirst Submitted
Initial submission to the registry
October 3, 2012
CompletedFirst Posted
Study publicly available on registry
October 4, 2012
CompletedOctober 4, 2012
October 1, 2012
3 months
October 3, 2012
October 3, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The difference of incidence of surgical site infection between both groups
Determine the difference in incidence of surgical site infection between Povidone Iodine 10% versus 7.5% hand scrub
4 month
Secondary Outcomes (1)
The difference in the side effects between both groups e.g. dermatitis
4 month
Study Arms (2)
Povidone Iodine 10%
EXPERIMENTALUsing Povidone Iodine 10% hand scrub before caesarian section
Povidone Iodine 7.5% hand scrub
EXPERIMENTALUsing Povidone Iodine 7.5% hand scrub before caesarian section
Interventions
Eligibility Criteria
You may qualify if:
- elective caesarian section (CS)
You may not qualify if:
- diabetes,
- immuno-compromised patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Women Health Hospital - Assiut university
Asyut, 71111, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
October 3, 2012
First Posted
October 4, 2012
Study Start
January 1, 2012
Primary Completion
April 1, 2012
Study Completion
May 1, 2012
Last Updated
October 4, 2012
Record last verified: 2012-10